Deucravacitinib Demonstrates Sustained Efficacy and Safety in 4-Year Psoriasis Trial
Dermatology Times
MAY 16, 2024
Bristol Myers Squibb announced 70% of patients maintained significant improvement after 4 years with no new safety concerns.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Dermatology Times
MAY 16, 2024
Bristol Myers Squibb announced 70% of patients maintained significant improvement after 4 years with no new safety concerns.
The Dermatology Digest
FEBRUARY 25, 2025
Deucravacitinib (Sotyktu, Bristol Myers Squibb) showed consistent safety and efficacy in patients with in moderate-to-severe plaque psoriasis for up to five years, new research shows. Moreover, the safety profile of deucravacitinib remained consistent through five years with no new safety signals identified.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kim Gallo Esthetics
FEBRUARY 27, 2024
The rise of transparency in ingredients, cruelty-free products, and sustainable packaging reflect not just our wish to appear youthful but our desire to live conscientiously. Recognizing skincare as a journey, not a race, is crucial for maintaining sustainable and lifelong skin health.
Dermatology Times
MAY 30, 2024
Novartis announced late-breaking data for the BTK inhibitor at the 2024 European Academy of Allergy and Clinical Immunology Congress.
The Dermatology Digest
MARCH 9, 2025
The safety and efficacy of dupilumab in BP are currently under clinical investigation and have not been evaluated by any regulatory authority. Sustained disease remission was defined as complete clinical remission with completion of OCS taper by week 16 without relapse and no rescue therapy use during the 36-week treatment period.
The Dermatology Digest
FEBRUARY 18, 2025
It was very encouraging in the ReNeu trial to see that Gomekli provided deep and durable responses, with a manageable safety profile that enabled patients to stay on therapy. Gomekli demonstrated a manageable safety and tolerability profile.
Dermatology Times
OCTOBER 11, 2023
The data presents compelling evidence for the sustained efficacy and safety of the oral JAK1 inhibitor in the treatment of moderate to severe atopic dermatitis over an extended 140-week period.
Fairlawn Aesthetic MD
JANUARY 10, 2025
This non-invasive therapy is designed to increase blood flow in the penis, resulting in stronger, more sustainable erections. Safety and Comfort: With no risky side effects, OrthoGold therapy ensures patient safety and comfort. This leads to harder, stronger, and more sustainable erections.
Spa Executive
MARCH 14, 2025
Security, safety, and sustainability Even in a tech-free setting, guests expect high levels of security and emergency responsiveness. AI and automation behind the curtain Software systems assist in managing staffing levels, guest flows, and wellness treatment availability to maintain a smooth guest experience.
The Dermatology Digest
MARCH 3, 2025
Add-on remibrutinib improved urticaria control as early as Week 2, with improvements sustained through Week 52, according to long-term results from the REMIX-1/-2 Phase 3 trials presented at the 2025 American Academy of Allergy Asthma and Immunology (AAAAI). versus 4.47), which was sustained through Week 52. vs. 1.95; REMIX-2: 5.57
The Dermatology Digest
JULY 27, 2023
Patricia Farris discusses skincare industry trends, including consumer demand for “clean beauty,” sustainability, and resources for consumer and dermatologist ingredient education. So we just don’t have the standardization of what is being eliminated and no consensus as to what should be eliminated based on safety studies.
Pivot Point International
OCTOBER 18, 2024
They are committed to sustainability, inclusivity, and social responsibility. About Pivot Point International Pivot Point International is a global leader in beauty education, providing innovative solutions and educational tools for over 60 years.
The Dermatology Digest
MAY 17, 2024
Deucravacitinib (Sotyktu, Bristol Myers Squibb) showed durable response rates and consistent safety in patients with moderate-to-severe plaque psoriasis after four years of continuous treatment, according to results from the POETYK PSO long-term extension (LTE) trial. patient-years (PYs) for the safety analyses. Year 4, 0.1)
Spa Executive
JULY 17, 2024
A growing consumer demand for sustainable and health-focused travel options is pushing the hospitality industry to innovate and prioritize wellness to meet these evolving expectations. Another critical challenge is navigating the balance between sanitation and sustainability.
Dermatology Times
JANUARY 20, 2025
In a real-world study, 10 children with generalized pustular psoriasis saw sustained improvements up to 160 weeks.
Dermatology Times
MARCH 14, 2025
Karl Yen of Sanofi discussed the role of amlitelimab in AD following sustained results and a promising safety profile presented in data at AAD.
The Dermatology Digest
MARCH 9, 2024
Safety in the FRONTIER 2 long-term extension study (week 16 through Week 52) was found to be consistent with FRONTIER 1. J&J has initiated the Phase 2b ANTHEM-UC study to evaluate the safety and effectiveness of JNJ-2113 compared with placebo in participants with moderately to severely active ulcerative colitis. at 52 weeks).
American Esthetician Organization
SEPTEMBER 13, 2023
Furthermore, Fur Love has successfully tapped into the growing demand for sustainable pet products. By aligning their values with those of environmentally conscious consumers, Fur Love has built a loyal following of pet owners who trust and appreciate their commitment to sustainability.
The Dermatology Digest
MAY 23, 2024
Bimekizumab-bkzx (Bimzelx, UCB) consistently showed sustained improvements in clinical and patient-reported outcomes in patients with moderate to severe hidradenitis suppurativa (HS), according to results from the Phase 3 BE HEARD I and BE HEARD II trials. Bimekizumab-bkzx is an interleukin (IL)-17A and IL-17F inhibitor.
Aesthetics Advisor
DECEMBER 8, 2023
Panacur-C for Cancer Buy on Amazon Fenbendazole side effects in humans Although safety data exists for various animals , the safety and tolerability of Fenbendazole in humans for sustained periods of time have not been thoroughly studied yet.
AAFE - American Academy of Facial Esthetics
APRIL 22, 2024
PRF Benefits: Longer Lasting Results: The fibrin matrix in PRF provides sustained release of growth factors, prolonging the rejuvenating effects compared to PRP. Versatility: PRP can be combined with other facial injectables such as hyaluronic acid fillers to augment their effects and prolong their duration.
The Dermatology Digest
OCTOBER 24, 2024
near-complete inhibition of pSTAT6 and sustained TARC inhibition out to nine months following a single dose These data will be presented at the American College of Allergy, Asthma & Immunology’s (ACAAI) 2024 Annual Scientific Meeting in Boston, MA.
Pivot Point International
OCTOBER 18, 2024
They are committed to sustainability, inclusivity, and social responsibility. About Pivot Point International Pivot Point International is a global leader in beauty education, providing innovative solutions and educational tools for over 60 years.
Les Nouvelles Esthetics & Spa
JANUARY 31, 2024
Navigating the regulatory processes is crucial to ensure your formulations comply with safety and quality benchmarks. Consider aspects such as your product’s shelf appearance, how it will feel in the consumers hands while using it, and the sustainability of your packaging.
West Lake Dermatology
SEPTEMBER 24, 2024
This mechanism of action is more aligned with the body’s natural processes, making it a more sustainable option for weight loss. Efficacy and safety: Numerous clinical studies have demonstrated the effectiveness and safety of GLP-1 agonists. of their body weight over 68 weeks, compared to just 2.4% in the placebo group.
The Dermatology Digest
MARCH 11, 2024
Sanofi’s investigational OX40-ligand blocker amlitelimab produces sustained improvement in the signs and symptoms of atopic dermatitis (AD) in adults who previously responded and continued treatment and sustained off-drug improvements in those who stopped treatment.
Lipgloss and Aftershave
DECEMBER 20, 2023
Natural NAD+ production gradually decreases with age, making it vital to replace NAD+ precursors that support sustained NAD+ levels as you get older. Endurance exercises like cycling boost energy-producing particles that support telomere integrity in skeletal muscle, which helps us sustain muscle mass as we age [26, 29].
The Dermatology Digest
APRIL 23, 2024
The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel. The BLA for pz-cel was accepted for filing and granted priority review designation by the FDA in November 2023.
The Dermatology Digest
MARCH 5, 2024
Pharmacokinetic (PK) data showed a half-life of approximately 75 days across doses tested and pharmacodynamic (PD) data showed, deep and sustained inhibition of key atopic dermatitis (AD) biomarkers pSTAT6 and TARC for ~3 months (longest follow-up available, with inhibition still ongoing at time of the data cut).
US Dermatologt Partners
JUNE 1, 2024
A study involving 245 patients showed significant improvements at 16 weeks, confirming its efficacy and safety in younger populations.6 7 Both apremilast and deucravacitinib have manageable safety profiles. 7 Both apremilast and deucravacitinib have manageable safety profiles.
The Dermatology Digest
JANUARY 23, 2024
Safety was assessed throughout the study. A significantly higher proportion of nemolizumab-treated patients showed early and sustained improvement in itch, the studies showed. Both studies met the co-primary, and key secondary endpoints with the outcomes being consistent between studies. in ARCADIA 2 when compared with placebo.
The Dermatology Digest
SEPTEMBER 30, 2024
The interim 28-week OLE data (as of March 1, 2024) showed dose-dependent sustained increases in Psoriasis Area and Severity Score (PASI) endpoint responses observed over time, with the majority of patients (93% as observed (AO, n=71), 82.7% These findings support use of the 40mg twice daily dose in the ongoing Phase 3 clinical program.
Spa Executive
JUNE 28, 2024
In 2024, wellness trends reflect a deepening commitment to sustainability, personalization, and cultural immersion, as individuals around the world seek to integrate these elements into their daily lives. Numerous developments across the region are intentionally designed to prioritize people’s health and wellbeing.
Cosmetify
JANUARY 15, 2024
Sampling and testing ensure that your products meet the highest standards of safety and effectiveness. Ensure compliance with safety standards and obtain necessary certifications. Transparency in labelling and adherence to regulations build trust among consumers, a vital aspect of sustaining a successful baby care brand.
Lipgloss and Aftershave
FEBRUARY 3, 2025
Whether it’s curating a signature facial or implementing safety standards, the left brain ensures precision and consistency. And that balance allows me to keep doing what I love while building a successful, sustainable practice. The not-so-fun, but crucial aspects of running a business cant be ignored.
Enlightened Beauty
AUGUST 2, 2024
While many clean beauty products do use natural ingredients, the focus is really on safety and effectiveness. It's like having a brainy best friend vet your products for ingredient safety and transparency. It's all about finding that sweet spot between safety and effectiveness. Another myth? stay radiant, — Morgan
Eminence Organics
JANUARY 20, 2024
But, in this era of environmental consciousness, we need a sustainable twist. This approach combines the rejuvenating experience of the Everything Shower with eco-friendly practices like using natural, sustainable products or water conservation methods. Enter the "Eco-Friendly Everything Shower."
The Beauty Brains
FEBRUARY 18, 2020
LA trip chat – Eco well sustainable beauty panel Beauty Science News #1 Is Deva curl making people’s hair fall out? There is actually good reason to avoid bakuchiol since it hasn’t been safety tested for use during pregnancy. It may be fine but until safety testing is done, I wouldn’t recommend it.
Aesthetics Advisor
JULY 25, 2024
Let's start with safety first. Although this is a relatively old case (2002), it is a good safety reminder on the potential danger of slimming products like slimming pills. For safe and healthy weight loss, you should avoid restrictive programs, such as the coffee diet, in favor of more sustainable plans. In 2015, the U.S.
Art of Dermatology
SEPTEMBER 6, 2023
When fraudulent, deceptive, or even just exaggerated environmental, health, and safety claims are made in the marketing of a product, that’s greenwashing. Greenwashing is not a new tactic. Everyone from hotels to oil companies has participated in greenwashed marketing. Some brands take advantage of this to sell more products.
New Age Spa Institute
JUNE 8, 2023
INGLOT places importance on ingredient safety, ethical practices and sustainability. INGLOT is not exclusively marketed as a “clean beauty” brand, but Inglot Cosmetics emphasizes certain aspects of clean beauty in its formulations and practices. They also offer a wide selection of vegan and cruelty-free cosmetic options.
Enlightened Beauty
JULY 14, 2023
Myth 5: "I Can’t Get Sunburned in the Water" Dipping in the water isn't a safety net from UV rays. This not only creates a concentrated formula that glides effortlessly on the skin, but it also marks a step towards a more sustainable approach in skincare. Water can reflect UV radiation, increasing your exposure.
The Dermatology Digest
AUGUST 28, 2024
There were meaningful and sustained improvements in skin aesthetic attributes, assessed using a Global Aesthetic Improvement Scale (“GAIS”), reported by the study investigators and subjects in both the décolleté and lateral canthal regions. Adverse events were primarily injection associated, mild-to-moderate, and transient.
The Beauty Brains
JANUARY 15, 2020
I guess the best that you might be able to do is to buy fewer products and buy from companies that have transparent sustainability programs. Now, you can buy cosmetic ingredients from home crafter suppliers but if you add up the environmental impact of making it yourself, that’s also not going to be better for the environment.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content